FRONTIERS IN ONCOLOGY

Visão geral
Metrics
Identidade
Informação adicional documento
Ver todos

Qualis

A4

código do país

CH

tipo

journal

publicação venue de

A Phase II Randomized Clinical Trial to Assess Toxicity and Quality of Life of Breast Cancer Patients with Hypofractionated Versus Conventional Fractionation Radiotherapy with Regional Nodal Irradiation in the context of COVID-19 crisis. 1:1-1. 2023-01-01
Addressing the unmet needs of patients with BRAF-mutated melanoma in Latin America: Expert perspective. 13:1-9. 2023-01-01
Angioimmunoblastic T-cell lymphoma and correlated neoplasms with T-cell follicular helper phenotype: from molecular mechanisms to therapeutic advances. 13:01-18. 2023-01-01
Breast cancer survival and the health system in Brazil: an analysis of public and private healthcare. 13:01. 2023-01-01
Can the sustainable development goals for cancer be met in Brazil? A population-based study. 12:1-12. 2023-01-01
Commentary: Functional bowel complaints and the impact on quality of life after colorectal cancer surgery in the elderly. 13:1-3. 2023-01-01
Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer. 13:x-x. 2023-01-01
Discrepancies in breast cancer?s oncological outcomes between public and private institutions in the southeast region of Brazil: a retrospective cohort study. 13:01-08. 2023-01-01
Does breast oncoplastic surgery improve quality of life?. 12:1099125. 2023-01-01
Editorial: Drug-resistance in cancer cells: A new wine in an old bottle. 13:1-2. 2023-01-01
Editorial: Reviews in molecular and cellular oncology. 13:1224902. 2023-01-01
Extranodal NK-T-cell lymphoma , nasal-type (ENKTCL-NT): What advances have been made in the last decade?. 1:01-17. 2023-01-01
Factors associated with unsatisfactory cosmetic results in oncoplastic surgery. 13:1071127. 2023-01-01
High frequency of WNT-activated medulloblastomas with CTNNB1 wildtype suggests a higher proportion of hereditary cases in a Latin-Iberian population. xx:xx-xx. 2023-01-01
Identifying Childhood Leukemia with an Excess of Hematological Malignancies in Firstd-degree Relatives in Brazil. 13:1-09. 2023-01-01
Liver transplantation in gastroenteropancreatic neuroendocrine tumors. 12:110-117. 2023-01-01
Management of patients with recurrent/metastatic endometrial cancer: Consensus recommendations from an expert panel from Brazil. 13:01-11. 2023-01-01
Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management. 13:1-18. 2023-01-01
Oncoplastic surgery for Paget?s disease of the breast. 13:1151932. 2023-01-01
Prospective study: Impact of breast magnetic resonance imaging on oncoplastic surgery and on indications of mastectomy in patients who were previously candidates to breast conserving surgery.. 13:01-08. 2023-01-01
Salivary glands adenoid cystic carcinoma: a molecular profile update and potential implications. 13:1-14. 2023-01-01
Somatic mutation detection and KRAS amplification in Testicular Germ Cell Tumors. 13:1-0. 2023-01-01
Stress induced phosphoprotein 1 overexpression controls proliferation, migration and invasion and is associated with poor survival in oral squamous cell carcinoma. 12:01-1085917. 2023-01-01
Sulforaphane: An emergent anti-cancer stem cell agent. 13:01-10-10. 2023-01-01
The increased antioxidant action of HDL is independent of HDL cholesterol plasma levels in triple-negative breast cancer. 13:01. 2023-01-01
miR-495-3p Regulates Cell Migration and Invasion in Papillary Thyroid Carcinoma. 13:1-11. 2023-01-01
A Novel Murine Model of a High Dose Brachytherapy-Induced Actinic Proctitis. 12:1-13-13. 2022-01-01
Alpha2beta1 Integrin Polymorphism in Diffuse Astrocytoma Patients. 12:12:914156.. 2022-01-01
An Emergent Role for Mitochondrial Bioenergetics in the Action of Snake Venom Toxins on Cancer Cells. 12:1-11. 2022-01-01
Anti-Migratory Effect of Dipotassium Glycyrrhizinate on Glioblastoma Cell Lines: Microarray Data for the Identification of Key MicroRNA Signatures. 12:.-.. 2022-01-01
Anticancer Properties of Curcumin Against Colorectal Cancer: A Review. 12:1-13. 2022-01-01
Association of JAK/STAT genetic variants with cutaneous melanoma. 1:1-na. 2022-01-01
Breast Cancer Phenotype Associated With Li-Fraumeni Syndrome: A Brazilian Cohort Enriched by TP53 p.R337H Carriers. 12:1. 2022-01-01
CRISPR Gene Editing of Human Primary NK and T Cells for Cancer Immunotherapy. 12:834002. 2022-01-01
Caustic stenosis of the esophagus and malignant neoplasia: A dilemma. 12:1-5. 2022-01-01
Cell-in-Cell Events in Oral Squamous Cell Carcinoma. 1:1. 2022-01-01
Characterization of genetic predisposition to molecular subtypes of breast cancer in Brazilian patients. 12:---. 2022-01-01
Complete Pathological Response After Neoadjuvant Chemo-Immunotherapy in Malignant Pleural Mesothelioma. 12:836751. 2022-01-01
Cost-Effectiveness of BRCA 1/2 Genetic Test and Preventive Strategies: Using Real-World Data From an Upper-Middle Income Country. 12:1. 2022-01-01
Detachment of Hexokinase II From Mitochondria Promotes Collateral Sensitivity in Multidrug Resistant Chronic Myeloid Leukemia Cells. 12:26;12:852985. 2022-01-01
Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer. 12:1. 2022-01-01
Editorial: Global Excellence in Oncology: Latin America 2022. -:-. 2022-01-01
Editorial: Impact of Breast MRI on Breast Cancer Treatment and Prognosis. 12:825101. 2022-01-01
Editorial: Multiplexed image analysis for translational research project applications. 12:eCollection 202. 2022-01-01
Editorial: Neoadjuvant Therapy in Rectal Cancer: Response Prediction and Organ Preservation Strategies. 12:944741. 2022-01-01
Editorial: Premalignant conditions in the esophagus and stomach. 12:1-4. 2022-01-01
Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination status. 12:954430. 2022-01-01
Emerging Therapies in Penile Cancer. 12:910335. 2022-01-01
Endoscopic Resection Versus Surgery in the Treatment of Early Gastric Cancer: A Systematic Review and Meta-Analysis. 12:939244. 2022-01-01
Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer. 12:1-16. 2022-01-01
Exploratory analysis of radiomic as prognostic biomarkers in 18F-FDG PET/CT scan in uterine cervical cancer. 02 Dec:01-08. 2022-01-01
Feasibility for Using Thermography Throughout an Exercise Program in Mastectomized Patients. 12:1-7. 2022-01-01
Gastric adenocarcinoma: 1-year overall survival, disability-adjusted life years, years of life lost, and prognostic factors-a single-institution experience. 12:01-15. 2022-01-01
Global Proteomics Analysis of Bone Marrow: Establishing Talin-1 and Centrosomal Protein of 55 kDa as Potential Molecular Signatures for Myelodysplastic Syndromes. 1:1-15. 2022-01-01
Glutathione levels are associated with methotrexate resistance in acute lymphoblastic leukemia cell lines. 12:01-18. 2022-01-01
HPV vaccination in Latin America: Coverage status, implementation challenges and strategies to overcome it. 12:1-12. 2022-01-01
Hereditary Breast Cancer in the Brazilian State of Ceará (The CHANCE Cohort): Higher-Than-Expected Prevalence of Recurrent Germline Pathogenic Variants. 12:1. 2022-01-01
Insights of Oncofertility in Mexico and Latin America. 12:1-3. 2022-01-01
Insights on variant analysis in silico tools for pathogenicity prediction. 13:1-14. 2022-01-01
Interplay Between Immune and Cancer-Associated Fibroblasts: A Path to Target Metalloproteinases in Penile Cancer. 12:1-1. 2022-01-01
Leukemic Stem Cell: A Mini-Review on Clinical Perspectives. 1:1-11. 2022-01-01
Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions. 12:1-25. 2022-01-01
Modelling of immune response in chronic myeloid leukemia patients suggests potential for treatment reduction prior to cessation. 12:.. 2022-01-01
Molecular Characterization of a First-in-Human Clinical Response to Nimesulide in Acute Myeloid Leukemia. 12:12. 2022-01-01
NON-CODING RNA IN PENILE CANCER. 12:1-7. 2022-01-01
Novel Insights From the Germline Landscape of Breast Cancer in Brazil. 11:1. 2022-01-01
P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma. 12:966404. 2022-01-01
Photobiomodulation Therapy in Management of Cancer Therapy-Induced Side Effects: WALT Position Paper 2022. 12:1-26. 2022-01-01
Primary Leiomyosarcoma of the Glans. 12:1-5. 2022-01-01
Primary Leomiyosarcoma of the Glans. 12:01-05. 2022-01-01
Recent HPV self-sampling use for cervical cancer screening in Latin America and Caribbean: a systematic review. 1:01-10. 2022-01-01
Recommendations for the prevention, screening, diagnosis, staging and management of cervical cancer in areas with limited resources.. 12:928560. 2022-01-01
Recommendations for the prevention, screening, diagnosis, staging, and management of cervical cancer in areas with limited resources: Report from the International Gynecological Cancer Society consensus meeting. 12:01-11. 2022-01-01
Recommendations for the treatment of vulvar cancer in settings with limited resources: Report from the International Gynecological Cancer Society consensus meeting. 12:1-11. 2022-01-01
Resistance Training Attenuates Activation of STAT3 and Muscle Atrophy in Tumor-Bearing Mice. 12:.-.. 2022-01-01
Socioeconomic, clinical, and molecular features of breast cancer influence overall survival of Latin American Women. 12:1-15. 2022-01-01
Somatic DNA Damage Response And Homologous Repair Gene Alterations And Its Association With Tumor Variant Burden In Breast Cancer Patients With Occupational Exposure To Pesticides. 12:--13. 2022-01-01
The Inflammatory Status of Soluble Microenvironment Influences the Capacity of Melanoma Cells to Control T-Cell Responses. 12:1-10. 2022-01-01
The Transcriptomic Portrait of Locally Advanced Breast Cancer and Its Prognostic Value in a Multi-Country Cohort of Latin American Patients. 12:835626-857. 2022-01-01
The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy. 12:1-20. 2022-01-01
What can we learn from more than 1,000 Brazilian patients at risk of hereditary cancer?. 12:1-x. 2022-01-01
miR-22 and miR-205 Drive Tumor Aggressiveness of Mucoepidermoid Carcinomas of Salivary Glands. 11:1-1. 2022-01-01
A 4-Gene Signature Associated With Recurrence in Low- and Intermediate-Risk Endometrial Cancer. 11:1-8. 2021-01-01
A Key Pathway to Cancer Resilience: The Role of Autophagy in Glioblastomas. 11:1. 2021-01-01
A Novel Ruthenium(II) Complex With Lapachol Induces G2/M Phase Arrest Through Aurora-B Kinase Down-Regulation and ROS-Mediated Apoptosis in Human Prostate Adenocarcinoma Cells. 11:1-18. 2021-01-01
An Immunometabolic Shift Modulates Cytotoxic Lymphocyte Activation During Melanoma Progression in TRPA1 Channel Null Mice. 11:1-14. 2021-01-01
Autophagy Regulation and Photodynamic Therapy: Insights to Improve Outcomes of Cancer Treatment. 10:1-22. 2021-01-01
Biological Pathways Associated With the Development of Pulmonary Toxicities in Mesothelioma Patients Treated With Radical Hemithoracic Radiation Therapy: A Preliminary Study. 11:1-13. 2021-01-01
Bone Marrow Soluble Immunological Mediators as Clinical Prognosis Biomarkers in B-Cell Acute Lymphoblastic Leukemia Patients Undergoing Induction Therapy. 11:1-12. 2021-01-01
Bone Marrow Soluble Mediator Signatures of Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms. 11:.-1. 2021-01-01
Breast Cancer Mortality in Young Women in Brazil. 10:1-6. 2021-01-01
Can Nimesulide Nanoparticles Be a Therapeutic Strategy for the Inhibition of the KRAS/PTEN Signaling Pathway in Pancreatic Cancer?. 11:1-16. 2021-01-01
Cancer-Related Characteristics Associated With Invasive Mechanical Ventilation or In-Hospital Mortality in Patients With COVID-19 Admitted to ICU: A Cohort Multicenter Study. 11:00-00. 2021-01-01
Cervical Cancer Stem-Like Cell Transcriptome Profiles Predict Response to Chemoradiotherapy. 11:00-14. 2021-01-01
Circulating Tumor Cells in Desmoid Tumors: New Perspectives. 11:1-626. 2021-01-01
Clinical and Molecular Properties of Human Immunodeficiency Virus-Related Diffuse Large B-Cell Lymphoma. 11:675353. 2021-01-01
Competing Endogenous RNA in Colorectal Cancer: An Analysis for Colon, Rectum, and Rectosigmoid Junction. 11:1-11. 2021-01-01
Copy number alterations in hepatoblastoma: literature review and a Brazilian cohort analysis highlight new biological pathways. 1:1. 2021-01-01
Corrigendum: The Profile of Immunophenotype and Genotype Aberrations in Subsets of Pediatric T-Cell Acute Lymphoblastic Leukemia.. 10:640629. 2021-01-01
Decreased Survival of Invasive Ductal Breast Cancer Patients With Two Macrometastatic Lymph Nodes Among Few Resected Ones: Should Current Sentinel-Lymph-Node Guidelines Be Revised?. 11:1-1. 2021-01-01
Development of Siglec-9 Blocking Antibody to Enhance Anti-Tumor Immunity. 11:.. 2021-01-01
Dysregulation of Transcription Factor Networks Unveils Different Pathways in Human Papillomavirus 16-Positive Squamous Cell Carcinoma and Adenocarcinoma of the Uterine Cervix. 11:.-.. 2021-01-01
Editorial: Human and Oncoviral Non-Coding RNAs as Modulators of Cancer Aggressiveness and Disease Progression. 10:1-2. 2021-01-01
Editorial: Nanomedicine in Cancer Targeting and Therapy. 11:1-4396. 2021-01-01
Editorial: New Roles of Autophagy Pathways in Cancer. x:x-x. 2021-01-01
Expression Profiling of Glioblastoma Cell Lines Reveals Novel Extracellular Matrix-Receptor Genes Correlated With the Responsiveness of Glioma Patients to Ionizing Radiation. 11:--14. 2021-01-01
Expression of Glycolysis-Related Proteins in Cancer of Unknown Primary Origin. 11:.-9. 2021-01-01
Glycogen Synthase Kinase-3 Beta Expression Correlates With Worse Overall Survival in Non-Small Cell Lung Cancer-A Clinicopathological Series. 11:1-10. 2021-01-01
IL6 and BCL3 Expression Are Potential Biomarkers in Esophageal Squamous Cell Carcinoma. 11:1-10. 2021-01-01
Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk. 11:1-10. 2021-01-01
Immunosuppression in Gliomas via PD-1/PD-L1 Axis and Adenosine Pathway. 10:1-9. 2021-01-01
In vivo efficacy and toxicity of curcumin nanoparticles in breast cancer treatment: a systematic review.. 11:1-18. 2021-01-01
Myosteatosis Differentially Affects the Prognosis of Non-Metastatic Colon and Rectal Cancer Patients: An Exploratory Study. 11:1. 2021-01-01
NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status. 11:1. 2021-01-01
Nano-Delivery of a Novel Inhibitor of Polynucleotide Kinase/Phosphatase (PNKP) for Targeted Sensitization of Colorectal Cancer to Radiation-Induced DNA Damage. 11:342. 2021-01-01
Overcoming Resistance to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinomas. 11:596290. 2021-01-01
Pediatric Acute Promyelocytic Leukemia: Epidemiology, Molecular Features, and Importance of GST-Theta 1 in Chemotherapy Response and Outcome.. 11:1. 2021-01-01
Perspectives on PARP Inhibitor Combinations for Ovarian Cancer. 11:754524-754524. 2021-01-01
Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. 11:1-11. 2021-01-01
Pulmonary Neuroendocrine Neoplasms Overexpressing Epithelial-Mesenchymal Transition Mechanical Barriers Genes Lack Immune-Suppressive Response and Present an Increased Risk of Metastasis. 11:1-251. 2021-01-01
Reviewr Article: Recent advances in brachytherapy using radioactive nanoparticles: an alternative to seed based brachytherapy. 11:1-1. 2021-01-01
The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells. 11:01/2021686445. 2021-01-01
The Fibrosis-Targeted Collagen/Integrins Gene Profile Predicts Risk of Metastasis in Pulmonary Neuroendocrine Neoplasms. 11:1-12. 2021-01-01
The Heparan Sulfate Binding Peptide in Tumor Progression of Triple-Negative Breast Cancer. 11:0697626. 2021-01-01
The Impact of Histopathological Features on the Prognosis of Oral Squamous Cell Carcinoma: A Comprehensive Review and Meta-Analysis. 1:1. 2021-01-01
The Role of Microglia in Glioblastoma. 10:1-8. 2021-01-01
Triggered drug release from liposomes: exploiting the outer and inner tumor environment. 11:1-23. 2021-01-01
Tumor Microenvironment Autophagic Processes and Cachexia: The Missing Link?. 10:1. 2021-01-01
Tumor Microenvironment Proteomics: Lessons From Multiple Myeloma. 11:1-10. 2021-01-01
Unraveling Immune-Related lncRNAs in Breast Cancer Molecular Subtypes. 11:1. 2021-01-01
Vitamin D Enhances Anticancer Properties of Cediranib, a VEGFR Inhibitor, by Modulation of VEGFR2 Expression in Melanoma Cells. 11:1. 2021-01-01
miRNome Profiling Reveals Shared Features in Breast Cancer Subtypes and Highlights miRNAs That Potentially Regulate MYB and EZH2 Expression. -:-. 2021-01-01
Autophagy regulation and photodynamic therapy: insights to improve outcomes of cancer treatment. 10:3121. 2020-01-01
B-Mode and Doppler Ultrasonography in a Murine Model of Ehrlich Solid Carcinoma With Different Growth Patterns. 10:01-10. 2020-01-01
Comparative Analysis of Systemic and Tumor Microenvironment Proteomes From Children With B-Cell Acute Lymphocytic Leukemia at Diagnosis and After Induction Treatment. -:--13. 2020-01-01
Comparison of microRNA Expression Profile in Patients Newly Diagnosed with Chronic Myeloid Leukemia and Treated by Allogeneic Hematopoietic Stem Cell Transplantation. 10:1-12. 2020-01-01
ESR1 Mutations Are Not a Common Mechanism of Endocrine Resistance in Patients With Estrogen Receptor-Positive Breast Cancer Treated With Neoadjuvant Aromatase Inhibitor Therapy. 10:1-7. 2020-01-01
Editorial: The Role of Modern Neuro-oncology in the Treatment of Primary CNS Tumors, and Brain and Spinal Metastases. 10:32582533. 2020-01-01
Emerging Autophagy Functions Shape the Tumor Microenvironment and Play a Role in Cancer Progression - Implications for Cancer Therapy. 10:10:606436. 2020-01-01
Epigenetic Mechanisms in Canine Cancer. 10:1. 2020-01-01
Human Endogenous Retrovirus Expression Is Upregulated in the Breast Cancer Microenvironment of HIV Infected Women: A Pilot Study. 10:553983. 2020-01-01
Inhibition of CAL27 Oral Squamous Carcinoma Cell by Targeting Hedgehog Pathway With Vismodegib or Itraconazole. 10:1-12. 2020-01-01
Insights Into the Somatic Mutation Burden of Hepatoblastomas From Brazilian Patients. 10:1-1-15. 2020-01-01
Insights in Osteosarcoma by Proton Nuclear Magnetic Resonance Serum Metabonomics. 10:1-20. 2020-01-01
Interplay between EGFR and the platelet-activating factor (PAF)/PAF receptor signaling axis mediates aggressive behavior of cervical cancer. 10:1. 2020-01-01
Intrinsic and Extrinsic Modulators of the Epithelial to Mesenchymal Transition: Driving the Fate of Tumor Microenvironment. 10:1. 2020-01-01
Local and Systemic STAT3 and p65 NF-KappaB Expression as Progression Markers and Functional Targets for Patients With Cervical Cancer. 10:.-.. 2020-01-01
Long non-coding RNAs involved in resistance to chemotherapy in ovarian cancer. 9:1549. 2020-01-01
Metastatic Squamous Cell Carcinoma to the Cervical Lymph Nodes From an Unknown Primary Cancer: Management in the HPV Era. 10:593164. 2020-01-01
Multifaceted WNT Signaling at the Crossroads Between Epithelial-Mesenchymal Transition and Autophagy in Glioblastoma. 10:10.3389/fonc.20-16. 2020-01-01
Mutational portrait of lung adenocarcinoma in Brazilian patients: past, present, and future of molecular profiling in the clinic. 10:1. 2020-01-01
NAP1L1: A Novel Human Colorectal Cancer Biomarker Derived From Animal Models of Apc Inactivation. 10:1565. 2020-01-01
Novel non-coding transcript in NR4A3 locus, LncNR4A3, regulates RNA processing machinery proteins and NR4A3 expression. 10:569668. 2020-01-01
Recurrence/Regrowth in Grade I Meningioma: How to Predict?. 10:01144-01144. 2020-01-01
Response Evaluation of Choroidal Melanoma After Brachytherapy Using Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI): Preliminary Findings. 10:825. 2020-01-01
Role of Genetic Ancestry in 1,002 Brazilian Colorectal Cancer Patients From Barretos Cancer Hospital. 10:1-12. 2020-01-01
Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease. 10:33194707. 2020-01-01
Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth. 10:575148. 2020-01-01
TERT promoter mutation C228T increases risk for tumor recurrence and death in head and neck cancer patients. 10:.-11. 2020-01-01
The Incidence of Node-Positive Non-small-Cell Lung Cancer Undergoing Sublobar Resection and the Role of Radiation in Its Management. 10:417. 2020-01-01
The Role of Autophagy in Tumor Immunology-Complex Mechanisms That May Be Explored Therapeutically. 10:1-12. 2020-01-01
Toxicoproteomics disclose pesticides as downregulators of TNF-α, IL-1β and estrogen receptor pathways in breast cancer women chronically exposed.. -:---. 2020-01-01
Using Co-segregation and Loss of Heterozygosity Analysis to Define the Pathogenicity of Unclassified Variants in Hereditary Breast Cancer Patients. 10:1-10. 2020-01-01
von Hippel-Lindau Syndrome: Genetic Study of Case With a Rare Pathogenic Variant With Optic Nerve Hemangioblastoma, a Rare Phenotypic Expression. 10:0000-144. 2020-01-01

tem uma área de assunto

publisher

Frontiers Media

is open access

True invalid format

is in DOAJ

True invalid format